AKT1 and colorectal carcinoma: However, the inhibition of activity by MK2206 (Akt phosphorylation inhibitor) partially decreased the positive effects of DJ‐1 on CRC cell invasion (Fig. 5D–E) and proliferation (Fig. 5F).